Corrigendum to “Rare-earth cerium-coordinated ICG nanoprobe for tumor hypoxia relief and intensified photodynamic therapy” [Mater. Today Bio 37 (2026) 102937]

The authors regret an error in the order of affiliations in the original article. The corrected affiliation list is presented above. In addition, the authors regret that an image-duplication error occurred in Fig. 4 on page 11 of the published article during figure assembly. Specifically, the corrected Fig. 4, containing the appropriate and distinct images for panels 4a and 4d, is provided below. Fig. S6 in the Supporting Information has also been updated accordingly. This correction does not affect the quantitative analyses, mechanistic interpretation, or conclusions of the article. The authors would like to apologise for any inconvenience caused.

Figure 4. In vitro anticancer mechanism of CINPs. (a) CLSM images of Hepa1-6 cells after different treatments via DCFH-DA staining for ROS generation investigation. (b) CLSM images of Hepa1-6 cells after different treatments via LPO staining for lipid peroxidation investigation. (c) CLSM images of Hepa1-6 cells after different treatments via γ-H2AX staining for DNA double-strand breakage investigation. (d) CLSM images of Hepa1-6 cells after different treatments via JC-1 staining for mitochondrial dysfunction investigation. “L” denotes exposure to 808 nm laser irradiation.

Figure S6. (a) CLSM images and (b) quantification of Hepa1-6 cells after incubation with different treatment groups and ROS staining (n = 3). “L” denotes exposure to 808 nm laser irradiation.